Herbert A, Stein K, Bryant T N, Breen C, Old P
Department of Histopathology, Southampton General Hospital, (Southampton University Hospitals NHS Trust), United Kingdom.
J Med Screen. 1996;3(3):140-5. doi: 10.1177/096914139600300307.
To examine the incidence of invasive cervical cancer per 100,000 women years at risk and relative risk according to screening history among eligible women aged 25-69 in Southampton and South West Hampshire during the three years after completion of the first round of comprehensive screening.
There was a significantly higher incidence of invasive cervical cancer in women who had not been screened during the preceding 0.5-5.5 years than in those who had been screened (relative risk (RR) 2.6; 95% confidence interval (CI) 1.6 to 4.3). Among the latter group of women (with interval cancers) there was a significantly higher incidence in those with a long interval of 3.5-5.5 years since their most recent smear than in those with a short interval of 0.5-3.5 years (RR 2.2; 95% CI 1.3 to 3.8). Among women with non-interval cancers, there was a significantly higher incidence among those who had no cytology record than among those who had been screened but were overdue for a smear (RR 3.0; 95% CI 1.2 to 7.3). When screen detected cancers were excluded from the figures the relative risks for all the comparative groups described above were greater, though the 95% confidence limits were wider because the numbers were smaller. The most pronounced difference in incidence was between symptomatic cancers in women with a short screening interval (5.8 per 100,000 women years at risk) and in women with no cytology record (71.3 per 100,000 years at risk). Most cancers were interval cancers (76%) because of the high screening coverage: 89.2% of eligible women aged 25-69 had been screened during the preceding 0.5-5.5 years. The overall incidence per 100000 women years at risk approached that of interval cancers, and was nearer to that observed in the short than the long interval because 74.7% of women had been screened within 3.5 years.
The results confirm the effectiveness of screening but suggest that a five year screening interval may be too long, at least during the early rounds of screening.
在第一轮全面筛查结束后的三年里,调查南安普顿和汉普郡西南部25 - 69岁符合条件的女性中,每10万名处于风险中的女性每年侵袭性宫颈癌的发病率以及根据筛查史得出的相对风险。
在之前0.5 - 5.5年未接受筛查的女性中,侵袭性宫颈癌的发病率显著高于接受过筛查的女性(相对风险(RR)为2.6;95%置信区间(CI)为1.6至4.3)。在后者(间隔期癌症患者)中,自最近一次涂片检查以来间隔时间为3.5 - 5.5年的女性发病率显著高于间隔时间为0.5 - 3.5年的女性(RR为2.2;95% CI为1.3至3.8)。在非间隔期癌症的女性中,没有细胞学记录的女性发病率显著高于接受过筛查但涂片检查逾期的女性(RR为3.0;95% CI为1.2至7.3)。当将筛查发现的癌症从数据中排除后,上述所有比较组的相对风险更大,不过由于数量较少,95%置信区间更宽。发病率最显著的差异存在于筛查间隔短的有症状癌症女性(每10万名处于风险中的女性每年5.8例)和没有细胞学记录的女性(每10万名处于风险中的女性每年71.3例)之间。由于筛查覆盖率高,大多数癌症为间隔期癌症(76%):89.2%的25 - 69岁符合条件的女性在之前0.5 - 5.5年接受过筛查。每10万名处于风险中的女性每年的总体发病率接近间隔期癌症的发病率,且更接近短间隔期观察到的发病率,因为74.7%的女性在3.5年内接受过筛查。
结果证实了筛查的有效性,但表明五年的筛查间隔可能太长,至少在早期筛查轮次中是这样。